L. Qin

发表

Current status and perspectives of patient-derived xenograft models in cancer research

Peng Li, Xinru Wei, P. Li, 2017, Journal of Hematology & Oncology.

Mixed lineage kinase-4 promotes gastric carcinoma tumorigenesis through suppression of the c-Jun N-terminal kinase signaling pathway

Dongmei Li, Y. Xi, L. Qin, 2018, Experimental and therapeutic medicine.

IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin

Baoxia Liang, Zhenfeng Zhang, Lin-Feng Xu, 2021, Journal of Hematology & Oncology.

Molecular modeling and epitopes mapping of human adenovirus type 3 hexon protein.

Yanhong Tang, Yuehui Zhao, Lei Shang, 2009, Vaccine.

IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells

Yangqiu Li, Suna Wang, D. Pei, 2020, Leukemia.

Incorporation of functional elements enhances the antitumor capacity of CAR T cells

P. Li, L. Qin, Peng Li, 2017, Experimental Hematology & Oncology.

Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells

Yangqiu Li, Yi-long Wu, Suna Wang, 2017, Journal of Hematology & Oncology.

The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection

D. Pei, P. Li, P. Lai, 2020, Leukemia.

Chimeric antigen receptor T cells targeting PD-L1 suppress tumor growth

Yangqiu Li, Zhenfeng Zhang, P. Li, 2020, Biomarker Research.

A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia

P. Li, P. Lai, Yulian Wang, 2018, Journal of Hematology & Oncology.

Lentinan relieves hepatitis B surface antigen induced functional impairment of monocytes/macrophages

Shanshan Huang, Chenwei Pan, Guang-yao Zhou, 2018 .

DAP10 integration in CAR-T cells enhances the killing of heterogeneous tumors by harnessing endogenous NKG2D

Yangqiu Li, Suna Wang, Zhenfeng Zhang, 2022, Molecular therapy oncolytics.

A novel non-viral PDCD1 site-integrated CAR design: killing 2 birds with 1 stone

Peng Li, L. Qin, Yuanbin Cui, 2022, Blood science.

Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis

J. Thiery, Suna Wang, Zhenfeng Zhang, 2022, Nature Communications.

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

Yangqiu Li, Suna Wang, Peng Li, 2017, Oncoimmunology.

Chimeric CTLA4-CD28-CD3z T Cells Potentiate Antitumor Activity Against CD80/CD86–Positive B Cell Malignancies

Suna Wang, W. Ye, Xiaofang Sun, 2021, Frontiers in Immunology.

Current status and hurdles for CAR-T cell immune therapy

L. Qin, Peng Li, Shanglin Li, 2019, Blood science.

Anti-adenovirus activities of shikonin, a component of Chinese herbal medicine in vitro.

Lei Shang, Zhang-yi Qu, L. Qin, 2011, Biological & pharmaceutical bulletin.

Disruption of CISH promotes the antitumor activity of human T cells and decreases PD-1 expression levels

L. Qin, Zhaoyang Tang, Peng Li, 2022, Molecular therapy oncolytics.

Human induced-T-to-natural killer cells have potent anti-tumour activities

Yangqiu Li, T. Graf, W. Feng, 2022, Biomarker research.

CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency

Suna Wang, Donghai Wu, Q. Deng, 2017, Scientific Reports.

Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells

D. Pei, P. Lai, J. Weng, 2018, Leukemia.

The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies

Yangqiu Li, Suna Wang, L. Qin, 2022, Frontiers in Immunology.

CRISPR/Cas9-Mediated Deletion of Foxn1 in NOD/SCID/IL2rg−/− Mice Results in Severe Immunodeficiency

Suna Wang, Donghai Wu, Q. Deng, 2017, Scientific Reports.

MiRNA-21 reverses high glucose and high insulin induced insulin resistance in 3T3-L1 adipocytes through targeting phosphatase and tensin homologue.

D. Liao, B. Hu, H. Ling, 2012, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

MiRNA-21 Reverses High Glucose and High Insulin Induced Insulin Resistance in 3 T 3L 1 Adipocytes through Targeting Phosphatase and Tensin

D. Liao, B. Hu, Shuidong Feng, 2012 .

T lymphocytes expressing the switchable chimeric Fc receptor CD64 exhibit augmented persistence and antitumor activity.

J. Thiery, N. Wong, Wenjing Guo, 2023, Cell reports.

The onco-embryonic antigen ROR1 is a target of chimeric antigen T cells for colorectal cancer.

Peng Li, L. Qin, Zhaoyang Tang, 2023, International immunopharmacology.

c-Met is a chimeric antigen receptor T-cell target for treating recurrent nasopharyngeal carcinoma.

Peng Li, Xinrui Zhang, L. Qin, 2023, Cytotherapy.

BCL11B and the NuRD complex cooperatively guard T‐cell fate and inhibit OPA1‐mediated mitochondrial fusion in T cells

Xingguo Liu, L. Qin, Yi Wu, 2023, The EMBO journal.

CD318 is a target of chimeric antigen receptor T cells for the treatment of colorectal cancer

Ming Li, L. Qin, Zhaoyang Tang, 2022, Clinical and Experimental Medicine.